Blog - Rose Hill Life Sciences

Rose Hill Life Sciences Executes Exclusive License Agreement with Johns Hopkins University for Restoration of Motor Function Post-Neurological Injury Using Psychedelics

Psychedelic Therapy

Psychedelics for Stroke Healing with Steven Zeiler, MD, PhD

Psychedelic Research

2025 Psychedelic Research Funding Trends and Their Impact on Psilocybin Development

Psilocybin Strain Diversity

Why Psilocybin Strain Diversity Matters in Clinical Research

Psychedelic Therapy in Mental Health

Psychedelic Therapy in Mental Health and Neurological Recovery

Hand touching indoor cluster of psilocybin mushrooms under soft natural light

How to Legally Import Psilocybin for Research (U.S., Canada, and EU)

Cluster of psilocybin mushrooms glowing on a mossy log in a forest setting

How Natural Psilocybin Differs from Synthetic Psilocybin (and Why It Matters)

Rose Hill Apothecary Executes First Major International Export Deal, Supplying Research-Grade Psilocybin to Brazil

Rose Hill Life Sciences to Spotlight Leading Research Partners at Psychedelic Science 2025

Rose Hill Life Sciences Appoints Biopharma Veteran Jama Pitman as Strategic Advisor